ACADIA Pharmaceuticals Inc

Common Name

ACADIA Pharmaceuticals

Country

United States

Sector

Healthcare

Industry

Biotechnology

Employees

653

Ticker

ACAD

Exchange

NASDAQ/NGS

Website

acadia.com

Description

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focusing on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorder... Show more

Financial Statements of ACADIA Pharmaceuticals

Below are the financial statements of ACADIA Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Assets	—	—
Cash and cash equivalents	319.59^a	188.66^a
Investment securities, available-for-sale	436.4^a	250.21^a
Accounts receivable, net	98.74^a	98.27^a
Interest and other receivables	5.96^a	4.08^a
Inventory	21.95^a	35.82^a
Prepaid expenses	55.68^a	39.09^a
Total current assets	938.32^a	616.13^a
Property and equipment, net	4.22^a	4.61^a
Operating lease right-of-use assets	46.57^a	51.86^a
Intangible assets, net	119.78^a	65.49^a
Restricted cash	8.77^a	5.77^a
Long-term inventory	69.74^a	4.63^a
Other assets	0.36^a	0.48^a
Total assets	1,187.76^a	748.96^a
Liabilities and stockholders’ equity	—	—
Accounts payable	16.19^a	17.54^a
Accrued liabilities	378.68^a	236.71^a
Total current liabilities	394.87^a	254.25^a
Operating lease liabilities	42.04^a	47.8^a
Other long-term liabilities	18.06^a	15.15^a
Total liabilities	454.96^a	317.2^a
Stockholders’ equity	—	—
Preferred stock	0^a	0^a
Common stock	0.02^a	0.02^a
Additional paid-in capital	2,936.87^a	2,862.55^a
Accumulated deficit	-2,204.39^a	-2,430.84^a
Accumulated other comprehensive income	0.29^a	0.02^a
Total stockholders’ equity	732.79^a	431.76^a
Total liabilities and stockholders’ equity	1,187.76^a	748.96^a

Verified Sources Behind ACADIA Pharmaceuticals’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore ACADIA Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. ACADIA Pharmaceuticals's 10-K 2024

Trace every data point back to ACADIA Pharmaceuticals’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

ACADIA Pharmaceuticals Inc

Financial Statements of ACADIA Pharmaceuticals

Verified Sources Behind ACADIA Pharmaceuticals’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

ADMA Biologics Inc

Axsome Therapeutics Inc

Insmed Inc

Apellis Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Cytokinetics Inc